Accenture’s data sharing platform climbs on Google Cloud

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/WDnet)
(Image: Getty/WDnet)

Related tags: Accenture, Google, Data management, Clinical data

Accenture’s Intient platform for clinical data management will use Google Cloud as a cloud technology provider.

Under a multi-year collaboration agreement with Google, Intient will be accessible on the Google Cloud platform, in order to benefit from Google’s cloud and artificial intelligence capabilities.

Launched in May 2019​, Intient is a technology platform enabling data sharing and management between scientists working on drug research and development, aiming to improve connectivity in the clinical research industry.

Google Cloud’s architecture, which supports open-source technology, is expected to enable Accenture to expand the capabilities of Intient by allowing partners, independent software vendors, and content providers to ‘rapidly’ develop and provide additional solutions that extend the value of the platform, Accenture stated.

Tariq Shaukat, president at Google Cloud, stated that, under this partnership, Google will work to “transform the life sciences industry with cloud technologies,” ​and added that the partners aim to accelerate developments of treatments “by leveraging powerful Google Cloud capabilities [...] to gain insights that correlate symptoms, events, and treatments in new and unexpected ways.”

The agreement occurred as an extension of an existing partnership between the two companies, which in 2018 led to the establishment of Accenture Google Cloud Business Group​, to assist various industries to work on digitalization.

An industry-wide data sharing approach

Accenture’s platform was built in collaboration with Oracle, based on an open-software architecture that allows users to modify its functions at will, with a spokesperson for Accenture telling us, at the time, that the company received significant interest from clients on the project prior to its launch.

Shortly after its launch, Intient was adopted by Bayer​, under an agreement which saw the latter company join the Life Sciences Cloud Coalition​, a group of businesses built by Accenture and Oracle in order to facilitate clinical data sharing within the industry.

According to the company, the coalition aims to enable ‘pre-competitive’ collaboration between companies and support quick and cost-effective advancement of clinical development.

Members of the Life Sciences Cloud Coalition include Pfizer, Eli Lilly, Bayer, Merck, Novo Nordisk and GlaxoSmithKline. With Bayer’s addition, a spokesperson for the company had stated that “The future of R&D is bright when leading organizations come together to solve patients’ greatest needs.”

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us


View more